NCT04130724 is a clinical trial of Blood ketone testing in Ketogenic Dieting, sponsored by Readout, Inc..

Who is sponsoring NCT04130724?

NCT04130724 is sponsored by Readout, Inc..

What drugs are being tested in NCT04130724?

Interventions in NCT04130724: Blood ketone testing, Breath ketone testing.

What condition does NCT04130724 study?

NCT04130724 studies Ketogenic Dieting, Ketosis.

Is NCT04130724 still recruiting?

NCT04130724 is currently completed. Last updated 17 December 2019.

Last reviewed 2019-12-17 · How we verify

NCT04130724

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Characterization of a Portable Solid-State Breath Acetone Testing Device for Real-Time Ketosis Status

Completed Last updated 17 December 2019

What this trial tests

trial testing Blood ketone testing in Ketogenic Dieting in 21 participants. Completed in 30 November 2019.

Timeline

16 October 2019

Primary endpoint
30 November 2019

30 November 2019

Quick facts

Lead sponsor	Readout, Inc.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	21
Start date	16 October 2019
Primary completion	30 November 2019
Estimated completion	30 November 2019
Sites	1 location across United States

Drugs / interventions tested

Blood ketone testing
Breath ketone testing

Conditions studied

Ketogenic Dieting — all drugs for Ketogenic Dieting →
Ketosis — all drugs for Ketosis →

Sponsor

Readout, Inc.

Who can join

18 and older, any sex, with Ketogenic Dieting or Ketosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary purpose of this study is to characterize the performance and utility of a novel breath acetone meter developed by Readout, Inc.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Characterization of a high-resolution breath acetone meter for ketosis monitoring.
Suntrup Iii DJ, Ratto TV, Ratto M, McCarter JP. · · 2020 · cited 15× · PMID 33024634 · DOI 10.7717/peerj.9969

Verify or expand the search:

Other recruiting trials for Ketogenic Dieting

Currently open trials in the same condition.

NCT03991897 — Nutritional Ketosis: a Novel Metabolic Strategy to Treat Lymphedema Patients? · NA · recruiting
NCT06065657 — Effect of Nutritional Ketosis on Alcohol Metabolism · Phase 2, PHASE3 · active not recruiting
NCT06115265 — Ketogenic Diet and Diabetes Demonstration Project · NA · recruiting
NCT04274179 — Ketogenic Diet for New-Onset Absence Epilepsy · Phase 3 · recruiting
NCT03665948 — Effect of Ketogenic and Carbohydrate Diet in Crossfit · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04130724 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Readout, Inc.
Last refreshed: 17 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04130724.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing